Vir Biotechnology Inc. (NASDAQ: VIR) reported Q4 EPS of ($0.86), $0.22 better than the analyst estimate of ($1.08). Revenue for the quarter came in at $16.8 million versus the consensus estimate of $12.07 million.

For earnings history and earnings-related data on Vir Biotechnology Inc. (VIR) click here.